ArticleJournal of gastrointestinal cancer2022

Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Mustafa Gürbüz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.